Thematic photoMartin FalbisonerCC BY-SA 3.0Resized, encoded as WebP; displayed with responsive cropping under the original licenceSEC EDGAR published this disclosure on 2026-09-09. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001104659-26-106341
acquired disposedD
codeD
direct or indirectD
form4
is derivativetrue
issuer nameBarinthus Biotherapeutics plc.
labelDisposition to issuer
Source record & verificationDates, provenance and technical details
Context
links are based on the recorded entity typeRecorded payloadStructured source data
Recorded payload
JSON payload as stored after parsing{
"accession": "0001104659-26-106341",
"acquired_disposed": "D",
"code": "D",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": true,
"issuer_name": "Barinthus Biotherapeutics plc.",
"label": "Disposition to issuer",
"person_name": "Phillips Anne M.",
"price": 0,
"role": "Director",
"security": "Share Option (Right to Buy)",
"shares": 18604,
"shares_owned_after": 0,
"source_path": "edgar/data/1828185/0001104659-26-106341.txt",
"ticker": "BRNS",
"transaction_date": "2026-09-09",
"value": null
}Evidence-based analysis
facts, provenance and explicit model coverageDescriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.